News 2017-02-17
Porton’s Annual Senior Management Working Conference.
Chongqing,China,February 17,2017: Porton Fine Chemicals, Ltd. held its annual senior management working conference on February 17, 2017. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed the Company’s progress made during 2016 and forward plans for 2017. Oliver Ju and Andrew Xu lauded the efforts of Porton’s employees towards achievement of FY 2016 revenue targets, and summarized the Company’s strategic initiatives for continued growth in FY 2017 and beyond.
Others
More
News 2025-03-21
Porton's Near-Term Target Validated by the SBTi
March 20, 2025, Chongqing—Porton Pharma Solutions Ltd. (Porton) announced today that its near-term greenhouse gas emissions reductions targets have been formally validated by the Science Based Targets initiative (SBTi). This milestone not only signifies its strategic breakthrough in climate governance, but also demonstrates that its decarbonization roadmap is aligned with the 1.5°C climate mitigation pathway.
News 2025-03-19
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T Cell Therapy Development
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
